Importantly, this peptide shows high selectivity
Across those trials the compound's tolerability was reported as comparable to placebo, with no statistically significant effects detected on serum IGF-1, fasting glucose, insulin, HbA1c, cortisol, or thyroid hormones at the levels studied, and no serious adverse events attributed to the compound [7]
Semaglutide has a deeper safety database
Administration technique affects absorption
If a patient is interested in BPC-157, the discussion should include why they are interested, what condition they are trying to address, what has already been diagnosed, what other treatments have been tried, what medications they take, and what safety questions apply
If that review goes badly, the fallout is mapped in our clinic playbook for a no vote on BPC-157